Sargon Site Network

Sargon Site Network is a clinical research site organization focused on providing high-quality trial execution services for the pharmaceutical and biotechnology industries. The company operates a network of integrated research sites that specialize in Phase 2 through Phase 4 clinical trials, emphasizing patient recruitment and data integrity. Sargon utilizes a centralized management model to standardize operations across its locations, aiming to reduce the administrative burden on sponsors and CROs. In November 2023, Sargon was acquired by Velocity Clinical Research, integrating its sites into one of the largest site networks in the United States. The acquisition allowed for the consolidation of high-performing sites under a single operational umbrella to better serve global clinical development programs.